2023
|
Invention
|
New therapy.
The present invention provides an oligonucleotide comprising the sequence 5′-GGAACA... |
|
Invention
|
Formulation.
The present invention relates a formulation and capsule suitable for oral administr... |
2022
|
Invention
|
Enema formulation. The present invention provides an aqueous formulation suitable for rectal admi... |
2021
|
Invention
|
Cobitolimod dosage for self-administration. The present invention provides an oligonucleotide com... |
2020
|
Invention
|
Oligonucleotide-based therapy for ulcerative colitis.
The present invention provides an oligonuc... |
|
Invention
|
Oligonucleotide-based therapy for ulcerative colitis. The present invention provides an oligonucl... |
2019
|
Invention
|
New therapy.
The present invention provides an oligonucleotide for use in preventing the recurre... |
|
Invention
|
New therapy. The present invention provides an oligonucleotide for use in preventing the recurren... |
|
Invention
|
Formulation. The present invention relates a formulation and capsule suitable for oral administra... |
2018
|
Invention
|
Cobitolimod for use in the treatment of inflammatory bowel disease. The present invention provide... |
|
Invention
|
Therapy. The present invention provides an oligonucleotide comprising the sequence 5′-GGAACAGTTCG... |
|
Invention
|
Cobitolimod for use in the treatment of inflammatory bowel disease. The present invention p... |
|
Invention
|
New therapy. The present invention provides an oligonucleotide comprising the sequence '-GGAACAGT... |
|
Invention
|
Compounds and methods for the treatment of inflammatory diseases of the cns.
Inflammatory diseas... |
2017
|
Invention
|
Method for prevention of colectomy.
A method of treating chronic active ulcerative colitis in a ... |
2016
|
Invention
|
Method for prevention of colectomy. A method of treating chronic active ulcerative colitis in a s... |
2015
|
Invention
|
Method for identifying biologically active oligonucleotides capable of modulating the immune syst... |
2014
|
Invention
|
Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells. M... |
2013
|
Invention
|
Method for predicting the response to a therapy.
A test kit for selecting a therapy for a steroi... |
2012
|
Invention
|
Method for prevention of colectomy. The present invention relates to methods of preventing or red... |
|
Invention
|
Immunostimulatory method. n-3′ wherein X is A, T, C, or G, Y is A, T, C, or G, m is 1-20 and n is... |
|
Invention
|
Method for modulating responsiveness to steroids. A method for enhancing steroid efficacy in a st... |
2011
|
Invention
|
Biologically active oligonucleotides capable of modulating the immune system ii. The present inve... |
|
Invention
|
Methods for identifying biologically active oligonucleotides capable of modulating the immune sys... |
|
Invention
|
Biologically active oligonucleotides capable of modulating the immune system i. The present inven... |
2009
|
Invention
|
Compounds and methods for the treatment of inflammatory diseases of the cns. Inflammatory disease... |
|
Invention
|
Increased expression of specific antigens.
The response of immunotherapy in the treatment of can... |
|
Invention
|
Increased expression of specific antigens. The response of immunotherapy in the treatment of canc... |
|
Invention
|
Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells. A... |
|
Invention
|
Combination therapies against cancer.
Specific oligonucleotide sequences, when given subcutaneou... |
2008
|
Invention
|
Method for predicting the response to a therapy. The invention concerns an in vitro method for se... |
|
Invention
|
Compounds for the treatment or alleviation of edema, and methods for their use. Isolated and subs... |
|
Invention
|
Tumour growth inhibitory compounds and methods of their use. Specific CpG oligonucleotide sequenc... |
2006
|
Invention
|
Immunostimulatory method. The present invention makes it possible to enhance steroid efficacy in ... |